08:51 AM EST, 02/20/2026 (MT Newswires) -- Aspire Biopharma Holdings ( ASBP ) said Friday that it has received a Nasdaq notice confirming the company has regained compliance with the $2.5 million minimum stockholders' equity requirement.

The biopharmaceutical company said earlier this month that it had also regained compliance with the $1 minimum bid price rule, placing Aspire back in full compliance with all Nasdaq continued listing standards and allowing its shares to remain listed.

Aspire said it was also notified by Nasdaq that the company will remain under a "Panel Monitor" through Feb. 18, 2027. If the company falls out of compliance with the equity requirement during that period, it would need to request a hearing rather than submit a compliance plan.